FDA approves breakthrough Alzheimer’s drug Lecanemab

Drug works with the body’s immune system to clear amyloid protein buildup from the brainThe US Food and Drug Administration (FDA) has approved Lecanemab, a breakthrough drug to treat Alzheimer’s, that is manufactured by biotechnology companies Biogen a…

Read More >>